Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study of Oraxol in Combination With Ramucirumab in Patients With Gastric, Gastro-esophageal, or Esophageal Cancers

NCT02970539 is registered in ClinicalTrials.gov with Athenex, Inc. as lead sponsor.

NCT NCT02970539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02970539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study of Oraxol in Combination With Ramucirumab in Patients With Gastric, Gastro-esophageal, or Esophageal Cancers
Lead sponsor
Athenex, Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
December 8, 2016
Completion date
December 31, 2022
Enrollment
36 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer, gastric cancer, gastro-esophageal cancer